On the other hand, our study found that HMOX1 was enriched in blood and immune cells, especially monocytes and macrophages, which were thought to be risk factors for the overall survival of glioma patients (Zhang et al., 2021a,b). This evidence concerns the gene HMOX1 and central nervous system cancer.